I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
As An Indispensable Element in Medical Practice, Imaging Continues to Evolve Providing the Cornerstone for the Growth of 3D/4D Visualization Systems
Recent Market Activity
Chronic Diseases & Aging Population Stretch Healthcare Resources Including Demand for Medical Imaging
Market Outlook
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Agfa-Gevaert Group (USA)
Canon Medical Systems USA Inc. (USA)
Carestream Health, Inc. (USA)
CONMED Corporation (USA)
Fujifilm Holding America Corporation (USA)
EOS Imaging (France)
GE Healthcare (UK)
Hitachi High-Technologies Corporation (Japan)
Koninklijke Philips N.V. (The Netherlands)
Siemens AG (Germany)
TeraRecon, Inc. (USA)
Thermo Fisher Scientific (USA)
TrueVision Systems, Inc. (USA)
Visage Imaging, Inc. (USA)
Vital Images, Inc. (USA)
Ziosoft (USA)
3. MARKET TRENDS & DRIVERS
Rise in Image Guided Surgeries Drives Demand for 3D/4D Imaging Systems &Visualization Tools
Rise of Telesurgery, a Revenue Spinning Trend in the Market
Epidemic Spread of Cancer Drives Interest in 4D Radiation Therapy (4DRT) Enabled by 4D Visualization Systems
Demand for Advanced Visualization Methods in Clinical Radiology Spurs Integration of 3D & 4D Visualization Tools with PACS
3D Image Sensors & 3D Displays: Vital Elements in Advanced 3D Visualization Systems
Collaborative Evaluation of 3D MRI, CT & Ultrasonic Imaging Data Strengthens the Business Case for Advanced Visualization Technologies
Developments in Interactive 3D Image Segmentation to Benefit Growth in the Market
Expanding Applications in Cardiology, Neurology Dentistry, Orthopedics & Gynecology
Advanced 3D/4D Visualization System Enhances Diagnostic Skill Acquisition and Supports Tactile Learning in Medical Training
Thin Client: The New Standard in Advanced Visualization
5D Imaging: Is it a Threat for 3D & 4D Visualization Software?
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Advanced (3D/4D) Visualization Systems by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for MRI by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for MRI by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for MRI by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Ultrasound by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Ultrasound by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Ultrasound by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Radio Therapy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Radio Therapy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Radio Therapy by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for CT by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for CT by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for CT by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for PET by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for PET by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for PET by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Nuclear Medicine by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Nuclear Medicine by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Nuclear Medicine by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Other Modalities by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other Modalities by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other Modalities by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Hospitals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 28: World Current & Future Analysis for Diagnostic Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Diagnostic Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Diagnostic Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 31: World Current & Future Analysis for Other End-Uses by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Other End-Uses by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Other End-Uses by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 34: USA Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: USA 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 37: USA Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: USA Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: USA 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
TABLE 40: Canada Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 43: Canada Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: Canada 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
TABLE 46: Japan Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 49: Japan Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
TABLE 52: China Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: China Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: China 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 55: China Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
TABLE 58: Europe Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 59: Europe Historic Review for Advanced (3D/4D) Visualization Systems by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: Europe 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 61: Europe Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: Europe Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: Europe 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 64: Europe Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
TABLE 67: France Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 68: France Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: France 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 70: France Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: France Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: France 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
TABLE 73: Germany Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: Germany Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: Germany 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 76: Germany Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: Germany Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: Germany 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
TABLE 79: Italy Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: Italy Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Italy 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 82: Italy Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Italy Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Italy 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 85: UK Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: UK Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: UK 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 88: UK Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: UK Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: UK 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
SPAIN
TABLE 91: Spain Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: Spain Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: Spain 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 94: Spain Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: Spain Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: Spain 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
RUSSIA
TABLE 97: Russia Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 98: Russia Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: Russia 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 100: Russia Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer